United States · Industrial & Consumer Products · USD (Thousands) · Annual
Reported figures and Equlion model projections for the next 5 years.
Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for Semler Scientific, Inc.? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | ||||
|---|---|---|---|---|---|---|
| Metric | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
| ROE | 27.04% | 19.2% | 17.32% | 14.26% | 12.47% | 11% |
|---|---|---|---|---|---|---|
| ROA | 25.73% | 18.51% | 16.75% | 13.83% | 12.13% | 10.73% |
| Gross Margin | 91.55% | 91.49% | 91.48% | 91.39% | 91.45% | 91.25% |
| Net Margin | 72.65% | 72.52% | 72.98% | 72.63% | 72.7% | 72.62% |
| Total Assets | $239,828.00K | $289,739.84K | $343,784.95K | $395,453.90K | $446,416.32K | $497,211.29K |
| Net Income | $40,899.00K | $49,004.04K | $53,046.53K | $51,100.49K | $51,057.94K | $50,616.84K |